Similar articles

• Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.

  Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, Li C, Golub TR, Rimm DL, Meyerson ML, Fisher DE, Sellers WR. Garraway LA, et al. Nature. 2005 Jul 7;436(7047):117-22. doi: 10.1038/nature03664. Nature. 2005. PMID: 16001072
• Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression.

  Shiraishi K, Yamasaki K, Nanba D, Inoue H, Hanakawa Y, Shirakata Y, Hashimoto K, Higashiyama S. Shiraishi K, et al. Oncogene. 2007 Jan 18;26(3):339-48. doi: 10.1038/sj.onc.1209800. Epub 2006 Jul 24. Oncogene. 2007. PMID: 16862184
• Microphthalmia-associated transcription factor gene amplification in metastatic melanoma is a prognostic marker for patient survival, but not a predictive marker for chemosensitivity and chemotherapy response.

  Ugurel S, Houben R, Schrama D, Voigt H, Zapatka M, Schadendorf D, Bröcker EB, Becker JC. Ugurel S, et al. Clin Cancer Res. 2007 Nov 1;13(21):6344-50. doi: 10.1158/1078-0432.CCR-06-2682. Clin Cancer Res. 2007. PMID: 17975146
• Lineage dependency and lineage-survival oncogenes in human cancer.

  Garraway LA, Sellers WR. Garraway LA, et al. Nat Rev Cancer. 2006 Aug;6(8):593-602. doi: 10.1038/nrc1947. Nat Rev Cancer. 2006. PMID: 16862190 Review.
• From integrated genomics to tumor lineage dependency.

  Garraway LA, Sellers WR. Garraway LA, et al. Cancer Res. 2006 Mar 1;66(5):2506-8. doi: 10.1158/0008-5472.CAN-05-4604. Cancer Res. 2006. PMID: 16510564 Review.